Roivant Sciences Ltd.
ROIV
71 insider filings · Latest: Oct 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Dec 29, 2025 | Dec 29 9:31 PM | Sukhatme Mayukh | Proposed Sale | 311,873 | $21.74 | $6.8M | — | View → |
| Dec 24, 2025 | Dec 29 2:36 PM | ERIC VENKER | Proposed Sale | 75,000 | $22.53 | $1.7M | — | View → |
| Dec 24, 2025 | Dec 29 2:05 PM | FRANK M TORTI | Proposed Sale | 64,891 | $22.47 | $1.5M | — | View → |
| Dec 23, 2025 | Dec 23 9:19 PM | RICHARD PULIK | Proposed Sale | 260,000 | $22.45 | $5.8M | — | View → |
| Dec 23, 2025 | Dec 23 9:07 PM | RICHARD PULIK TRUST | Proposed Sale | 146,731 | $22.39 | $3.3M | — | View → |
| Dec 23, 2025 | Dec 23 9:04 PM | ERIC VENKER | Proposed Sale | 200,000 | $22.45 | $4.5M | — | View → |
| Dec 17, 2025 | Dec 17 10:09 PM | Sukhatme Mayukh | Proposed Sale | 26,831 | $23.09 | $619.5K | — | View → |
| Dec 15, 2025 | Dec 15 10:13 PM | Gline Matthew | Proposed Sale | 1,740,000 | $21.68 | $37.7M | — | View → |
| Dec 15, 2025 | Dec 15 9:36 PM | Gline Matthew | Proposed Sale | 1,740,000 | $21.68 | $37.7M | — | View → |
| Dec 9, 2025 | Dec 9 9:49 PM | Venker Eric | Proposed Sale | 200,000 | $20.85 | $4.2M | — | View → |
| Nov 7, 2025 | Nov 7 8:15 PM | Venker Eric | Proposed Sale | 200,000 | $20.22 | $4.0M | — | View → |
| Oct 17, 2025 | Oct 17 8:01 PM | Venker Eric | Proposed Sale | 118,418 | $17.06 | $2.0M | — | View → |
| Oct 16, 2025 | Oct 16 8:37 PM | Venker Eric | Proposed Sale | 318,282 | $17.05 | $5.4M | — | View → |
| Oct 15, 2025 | Oct 15 8:23 PM | Venker Eric | Proposed Sale | 414,683 | $16.93 | $7.0M | — | View → |
| Oct 13, 2025 | Oct 14 12:51 PM | Venker Eric | Proposed Sale | 20,727 | $16.25 | $336.9K | — | View → |
| Oct 9, 2025 | Oct 9 8:12 PM | Venker Eric | Proposed Sale | 104,940 | $16.30 | $1.7M | — | View → |
| Oct 8, 2025 | Oct 8 8:15 PM | Venker Eric | Proposed Sale | 138,602 | $16.20 | $2.2M | — | View → |
| Oct 7, 2025 | Oct 7 8:34 PM | Venker Eric | Proposed Sale | 355,161 | $16.15 | $5.7M | — | View → |
| Oct 6, 2025 | Oct 6 8:46 PM | Venker Eric | Proposed Sale | 171,396 | $16.34 | $2.8M | — | View → |
| Sep 23, 2025 | Sep 23 1:45 PM | Venker Eric | Proposed Sale | 611,079 | $14.94 | $9.1M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Oct 5 10:05 PM | Melissa B, EpperlyDirector | Option Exercise | 17,750 | $4.46 | 151,416(D) | View → |
| Sep 30, 2026 | Oct 2 9:37 PM | Eric VenkerPresident & Immunovant CEO | Option Exercise | 200,000 | $3.85 | 3,644,834(D) | View → |
| Sep 16, 2026 | Sep 19 1:00 AM | Keith S ManchesterDirector | Grant/Award | 10,531 | $39.57 | 10,531(D) | View → |
| Sep 16, 2026 | Sep 18 11:12 PM | Daniel Allen GoldDirector | Grant/Award | 10,531 | $39.57 | 10,531(D) | View → |
| Sep 16, 2026 | Sep 18 11:06 PM | Ilan OrenDirector | Grant/Award | 10,531 | $39.57 | 10,531(D) | View → |
| Sep 16, 2026 | Sep 18 11:01 PM | James C MomtazeeDirector | Grant/Award | 10,531 | $39.57 | 10,531(D) | View → |
| Sep 16, 2026 | Sep 18 10:57 PM | Meghan FitzgeraldDirector | Grant/Award | 10,531 | $39.57 | 10,531(D) | View → |
| Sep 16, 2026 | Sep 18 10:56 PM | Melissa B, EpperlyDirector | Grant/Award | 10,531 | $39.57 | 10,531(D) | View → |
| Sep 8, 2026 | Sep 11 1:00 AM | Meghan FitzgeraldDirector | Option Exercise | 20,000 | $8.80 | 18,578(D) | View → |
| Aug 28, 2026 | Sep 2 1:00 AM | Eric VenkerPresident & Immunovant CEO | Option Exercise | 200,000 | $3.85 | 3,844,834(D) | View → |
| Aug 21, 2026 | Aug 22 1:00 AM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 144,756 | $3.85 | 13,224,363(D) | View → |
| Aug 20, 2026 | Aug 22 1:00 AM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 17,519 | $3.85 | 13,369,119(D) | View → |
| Aug 19, 2026 | Aug 22 1:00 AM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 172,899 | $3.85 | 13,386,638(D) | View → |
| Aug 18, 2026 | Aug 19 1:00 AM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 136,942 | $3.85 | 13,559,537(D) | View → |
| Aug 17, 2026 | Aug 19 1:00 AM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 284,707 | $3.85 | 13,696,479(D) | View → |
| Aug 14, 2026 | Aug 19 1:00 AM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 243,177 | $3.85 | 13,981,186(D) | View → |
| Jul 27, 2026 | Jul 30 1:00 AM | Eric VenkerPresident & Immunovant CEO | Option Exercise | 200,000 | $3.85 | 4,044,834(D) | View → |
| Jun 30, 2026 | Jul 2 11:03 PM | Meghan FitzgeraldDirector | Option Exercise | 10,000 | $8.80 | 38,578(D) | View → |
| Jun 29, 2026 | Jul 1 10:34 PM | Melissa B, EpperlyDirector | Option Exercise | 17,750 | $4.46 | 169,166(D) | View → |
| Jun 26, 2026 | Jun 29 10:23 PM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 500,000 | $3.85 | 14,224,363(D) | View → |
Page 1 of 2
Next →